Trinity Biotech Plc - Company Profile

Powered by

All the sales intelligence you need on Trinity Biotech Plc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Trinity Biotech Plc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Trinity Biotech Plc.

Back to companies

Trinity Biotech Plc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

The following section provides information on Trinity Biotech Plc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Trinity Biotech Plc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

John Gillard

Chief Executive Officer; President; Director Executive Board Since: 2020 Age: 45

Mr. John Gillard has been the Director, Chief Executive Officer, President of the company since 2023. Prior to this, he served as the Executive Director, Chief Financial Officer, Director, and Secretary of the company. Previously, he held various of senior financial roles at Alphabet Inc./Google, ION Investment Group.

Read Hide full bio of John Gillard

Eibhlin Kelly

Chief Information Officer Senior Management Since: 2015

Ms. Eibhlin Kelly has been the Chief Information Officer of the company since 2015. Prior to this, she served as the Customer Services Manager at Lynq Limited. Previously, she served as the Service Delivery/Support Manager at Trinity Biotech.

Read Hide full bio of Eibhlin Kelly

Gary Keating, Ph.D

Chief Technology Officer Senior Management Since: 2022 Age: 53

Mr. Gary Keating has been the Chief Technology Officer of the company since 2022. Prior to this, he served as the Transfer Manager at Abbott Diagnostics, R&D Manager at Diasorin Ireland, and CTO at HiberGene Ltd.

Read Hide full bio of Gary Keating, Ph.D

Susan O’Connor

Interim Chief Financial Officer Senior Management Since: 2025

Ms. Susan O’Connor has been the Interim Chief Financial Officer of the company since 2025. Prior to this, she served as the Chief Financial Officer of Glantus Holdings plc.

Read Hide full bio of Susan O’Connor

Jim Walsh, Ph.D.

Director; Director - Business Development Executive Board Since: 2015 Age: 66
Gain a 360-degree view of Trinity Biotech Plc and make more informed decisions for your business Gain a 360-degree view of Trinity Biotech Plc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer